Low-dose Dexamethasone in Newly Diagnosed Pulmonary Sarcoidosis
Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This trial examines whether low grade suppression of the initial inflammatory process of
sarcoidosis by intervention with low-dose dexamethasone therapy achieves significant
alleviation of (sub-)acute symptoms, improvement in quality of life, increase in work
productivity, and whether this intervention prevents disease progression and reduces total
health-care costs.